Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
New England Journal of Medicine · 26.02.2026 · 394 (9) · 858-871
DOI: 10.1056/nejmoa2508228 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 26.02.2026. Verfasst von Aadia I Rana und 36 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Heersink School of Medicine, Birmingham. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Alabama at Birmingham, Heersink School of Medicine, Birmingham.
- Harvard T.H. Chan School of Public Health, Boston.
- ViiV Healthcare, Durham, NC.
- University of Colorado Anschutz Medical Campus, Aurora.
- Frontier Science Foundation, Amherst, NY.
- UTHealth Houston, Houston.
ORCID-Profile: Aadia I Rana
Förderung
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
Zitieren
APA
Rana, A. I., Zheng, L., Castillo-Mancilla, J., Bao, Y., Sieczkarski, S., Brooks, K. M., Lake, J. E., Fichtenbaum, C., Heath, S. L., Belaunzaran-Zamudio, P. F., Klingman, K., Fox, L., Morton, T., Stirratt, M., Li, J. Z., Acosta, E. P., Venuto, C., Galárraga, O., Shoptaw, S., …, & ACTG A5359 LATITUDE Trial Team (2026). Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. New England Journal of Medicine, 394(9), 858-871. https://doi.org/10.1056/nejmoa2508228
Vancouver
Rana AI, Zheng L, Castillo-Mancilla J, Bao Y, Sieczkarski S, Brooks KM, et al. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. New England Journal of Medicine. 2026;394(9):858-871. doi:10.1056/nejmoa2508228
BibTeX
@article{Rana2026,
author = {Rana, Aadia I and Zheng, Lu and Castillo-Mancilla, Jose and Bao, Yajing and Sieczkarski, Sara and Brooks, Kristina M and Lake, Jordan E and Fichtenbaum, Carl and Heath, Sonya L and Belaunzaran-Zamudio, Pablo F and Klingman, Karin and Fox, Lawrence and Morton, Tia and Stirratt, Michael and Li, Jonathan Z and Acosta, Edward P and Venuto, Charles and Galárraga, Omar and Shoptaw, Steven and Wohl, David and Green, Madison and Beijer, Ceora and Ferbas, Kathie and Jennings, Cheryl and Shin, Katherine and Collahua, Romina and Dorosh, Michael and Wannamaker, Paul and D'Amico, Ronald and Smith, Kimberly and Spreen, William and Vandermeulen, Kati and Van Solingen-Ristea, Rodica and Wimbish, Chanelle and Tashima, Karen T and Landovitz, Raphael J and ACTG A5359 LATITUDE Trial Team, ACTG A5359 LATITUDE Trial Team},
title = {Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {9},
pages = {858--871},
doi = {10.1056/nejmoa2508228}
}
EUVIMED